Market Inference Brief -- MET Stock

During the afternoon session, MetLife moved -3.58%, compared to -0.25% for the S&P 500.

MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. The company is now trading -20.06% away from its average analyst target price of $83.5 per share. The 14 analysts following the stock have set target prices ranging from $78.0 to $90.0, and on average give MetLife a rating of buy.

Over the last year, MET shares have gone up 15.06%, which represents a difference of 21.87% when compared to the S&P 500. The stock's 52 week high is $76.81 per share whereas its 52 week low is $56.17. With its operating margins declining an average -2.26% over the last four years, MetLife may not have a strong enough business to keep this trend.

Date Reported Revenue (k) Cost of Revenue (k) Gross Margin YoY Growth
2022-12-31 $69,898,000 $118,359,000 -69.33% -34.67%
2021-12-31 $71,080,000 $107,672,000 -51.48% 1.85%
2020-12-31 $67,842,000 $103,424,000 -52.45% -2.56%
2019-12-31 $69,620,000 $105,226,000 -51.14% 7.09%
2018-12-31 $67,941,000 $105,334,000 -55.04% n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.